MacroGenics

MARGENZA

  1. Home
  2.  / 
  3. J Code
  4.  / MARGENZA – J9353

Manufacturer:

MacroGenics

Name:

MARGENZA

HCPCS Code Descriptor:

Injection, margetuximab-cmkb, 5 mg

Category:

J Code

HCPCS:

J9353

NDC(s):

74527-0022-02, 74527-0022-03

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

MARGENZA is an Oncology drug manufactured by MacroGenics and administered via the Intravenous route of administration. The J Code: J9353 is aligned to the drug MARGENZA.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/21

HCPCS Effective Date:

7/1/21

HCPCS Short Description:

Inj. margetuximab-cmkb, 5 mg

Billing and Coding Guide:

https://www.margenza.com/pdf/margenza-billing-and-coding-guide.pdf

Patient Assistance:

https://www.margenzasupport.com/

MARGENZA - J9353